Literature DB >> 6605929

Induction of interleukin 1 secretion by adjuvant-active peptidoglycans.

F Vacheron, M Guenounou, C Nauciel.   

Abstract

The ability of differently structured, purified peptidoglycans (PG) to induce interleukin 1 (IL1) secretion was compared. PG from Bacillus megaterium and Staphylococcus aureus stimulated the production of IL1 by mouse peritoneal macrophages and human adherent mononuclear cells, whereas PG from Micrococcus lysodeikticus and Corynebacterium poinsettiae were inactive. There was a correlation between the ability of PG to induce IL1 secretion and previously demonstrated immunoenhancing activities (adjuvant effect, increase of resistance to tumor growth) of PG. PG solubilization by lysozyme decreased but did not abolish the PG effect on IL1 secretion. Active PG induced IL1 production in nude mice and in the C3H/HeJ strain (which is unresponsive to lipopolysaccharides).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605929      PMCID: PMC264406          DOI: 10.1128/iai.42.3.1049-1054.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response.

Authors:  C Nauciel; J Fleck; J P Martin; M Mock; H Nguyen-Huy
Journal:  Eur J Immunol       Date:  1974-05       Impact factor: 5.532

2.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

3.  Inhibition of tumor growth by the peptidoglycan from Bacillus megaterium.

Authors:  C Nauciel; A F Goguel
Journal:  J Natl Cancer Inst       Date:  1977-12       Impact factor: 13.506

4.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

6.  Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity.

Authors:  C Damais; C Bona; L Chedid; J Fleck; C Nauciel; J P Martin
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

7.  Migration inhibition of rat peritoneal cells induced by streptococcal mucopeptides. Characteristics of the reaction and properties of the mucopeptide preparations.

Authors:  B Heymer; B Bültmann; W Schachenmayr; R Spanel; O Haferkamp; W C Schmidt
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

8.  [Adjuvant activity of monomeric fractions of bacterial peptidoglycans in delayed hypersensitivity].

Authors:  C Nauciel; J Fleck; M Mock; J P Martin
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1974-12-17

9.  The adjuvanticity of interleukin 1 in vivo.

Authors:  M J Staruch; D D Wood
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

10.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

View more
  10 in total

1.  Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide.

Authors:  T A Flak; L N Heiss; J T Engle; W E Goldman
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  The macrophage response to bacteria. Modulation of macrophage functional activity by peptidoglycan from Moraxella (Branhamella) catarrhalis.

Authors:  R Keller; J E Gustafson; R Keist
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

3.  A limited role of IL-1 in immune-enhancement by adjuvants.

Authors:  T Sagara; S Mori; S Ohkawara; F Goto; K Takagi; M Yoshinaga
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

4.  Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate.

Authors:  S Kotani; H Takada; I Takahashi; M Tsujimoto; T Ogawa; T Ikeda; K Harada; H Okamura; T Tamura; S Tanaka
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

5.  Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.

Authors:  Chelsea A Embry; Luigi Franchi; Gabriel Nuñez; Thomas C Mitchell
Journal:  Sci Signal       Date:  2011-05-03       Impact factor: 8.192

6.  Production of interleukin-12 by murine macrophages in response to bacterial peptidoglycan.

Authors:  C Lawrence; C Nauciel
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

7.  Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli.

Authors:  T Koga; T Nishihara; T Fujiwara; T Nisizawa; N Okahashi; T Noguchi; S Hamada
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

8.  Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide.

Authors:  G G Wright; G L Mandell
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

9.  Preventive Effects of Heat-Killed Enterococcus faecalis Strain EC-12 on Mouse Intestinal Tumor Development.

Authors:  Shingo Miyamoto; Masami Komiya; Gen Fujii; Takahiro Hamoya; Ruri Nakanishi; Kyoko Fujimoto; Shuya Tamura; Yurie Kurokawa; Maiko Takahashi; Tetsuo Ijichi; Michihiro Mutoh
Journal:  Int J Mol Sci       Date:  2017-04-13       Impact factor: 5.923

Review 10.  The controversial role of Enterococcus faecalis in colorectal cancer.

Authors:  Carolina Vieira de Almeida; Antonio Taddei; Amedeo Amedei
Journal:  Therap Adv Gastroenterol       Date:  2018-06-26       Impact factor: 4.409

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.